Lab Manager | Run Your Lab Like a Business

New Report Unveils Hottest Industry Trends in Life Sciences Sector 2014

Meaningful “quick read” whitepaper “Life Science Trends 2014” also offers exclusive feature article on Big Data in the Life Sciences.

by george james Ltd.
Register for free to listen to this article
Listen with Speechify
0:00
5:00

Buckinghamshire, UK (April, 22nd, 2014) – george james Ltd., a leading provider of recruitment, training and corporate development services to the scientific industry, has announced the availability of a new report “Life Science Trends 2014,” which outlines trends and innovations in the life sciences industry. Written in conjunction with Carlyle Conlan, the report encompasses drugs, biologics, devices and diagnostics sectors, summarising a variety of the most up to date industry news. It demonstrates significant advances in the industry from the past year and highlights observations about developments of interest throughout the year ahead. To obtain a free copy of the report please click here.

Designed as a meaningful “quick read” whitepaper, the report is separated into several macro headers: Research and Innovation, Fundamental Trends, Investing and Deal Making, Regulatory and Government and Health Care. The report is essential reading for those working in the pharmaceutical and biotech industries who are not only looking for an overall summary, but a resource to explore deeper, dependant on the individual interest of the reader.

Get training in Lab Crisis Preparation and earn CEUs.One of over 25 IACET-accredited courses in the Academy.
Lab Crisis Preparation Course

In addition, the essential annual report also includes an exclusive feature article “Big Data in the Life Sciences”, which highlights commentary and interviews from several key senior industry professionals involved in big data breakthroughs in the life sciences sector. This feature article demonstrates how the enormous increase in data volume from segments like sequencing and systems biology, coupled with trends in pre-competitive data sharing and advanced computing frameworks, is in the early stages of providing robust signals, that will ultimately decrease the cost of drug development and maximise the industry’s return on investment.

Neil Burns, Founding Director at george james Ltd, said: “We are very pleased that this report has been published and is now easily available to download from our website. It has been structured in a way which is easy to read for industry professionals in pharma and biotech to keep informed but still can be researched further. We at george james strive help our customers achieve their core goals and specialisation and hope this report offers premium research of value to the life sciences sector.”

Don Alexander, Practice Head and Vice President, Life Sciences at Carlyle Conlan, comments: “We are very pleased to be able to, with the support of George James, have a report available for the public to read which covers such a wide range of articles across pertinent areas such as Health Care, Research and Innovation. What makes our report different is that an early version is sent to CEOs, venture capitalists and other industry experts for review before its final release and created using both primary and secondary data. We invite you to review the information contained in the report which we hope you will find relevant and interesting.”